As the opioid epidemic continues across America, more communities are providing their law enforcement officers with the drug naloxone (sold as Narcan) to reverse overdoses. Prosecutor Joseph D. Coronato of Ocean County, NJ, discussed the profound benefits he has seen as a result of the county’s naloxone program.
As the opioid epidemic continues across America, more communities are providing their law enforcement officers with the drug naloxone (sold as Narcan®) to reverse overdoses. Prosecutor Joseph D. Coronato of Ocean County, NJ, discussed the profound benefits he has seen as a result of the county’s naloxone program.
Transcript (slightly modified)
What effect has the Narcan program had on the local police officers?
Narcan has really turned out to have several advantages. Not only are we saving the life of that individual, making a difference where you’re bringing back from the light as they almost walked into the light, but more importantly it’s changed the image of who the victim is, who that individual is. It’s somebody’s son, it’s somebody’s daughter, it’s someone’s loved one, and I think the police officers now can relate better to that.
I think the other thing is that before they were just standing around being helpless. The other people would say “do something, do something,” but there was nothing that they could do. They had to wait for either the first aid squad or EMTs to show up. Now they can actively participate, and what happens is once they do participate and they bring that person back to life, to them it’s a life-changing moment. We have acknowledged that by acknowledging that police officer for completing that event and doing a tremendous job.
It’s heartwarming to the police officer, I think it’s changed the image of the police officer, and it’s also changed the image in the police officer’s eye of that individual who almost died. So the result is that there’ve been many, many different advantages to the Narcan program besides the fact that we brought somebody from the jaws of death.
Balancing Life and Myeloma: A Patient-Centered Approach
November 22nd 2024In this second part of our discussion with Don M. Benson, MD, PhD, from our recent Institute for Value-Based Medicine® event in Cleveland, Ohio, he explains how his ultimate goal for his patients is for them to live as long and as well as possible.
Read More
Community Investment, Engagement Are Essential to Fully Address Cardiovascular Health Disparities
November 19th 2024Community-based researchers can teach clinicians a lot about how to best approach underserved populations disproportionately impacted by cardiovascular health complications.
Read More